Olson GE, Whitin JC, Hill KE, Winfrey VP, Motley AK, Austin LM et al
Changing landscape: Recent legislative proposals, including provisions in the Treat and Reduce Obesity Act, aim to remove the federal exclusion and require Medicaid to cover weight loss drugs
While most people associate GLP-1s with weight loss, the science reveals something far more exciting: these medications offer profound benefits beyond the scale
(42:52) The hack to being successful in life
Based on PCSK9 binding data and manufacturability characteristics (i.e
Although GLP-1 patches are not currently licensed in the UK, the following guidance applies broadly to transdermal medication systems and would be relevant should such products become available